Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
TVGN Tevogen Bio Holdings
- 1.580
- +0.020+1.28%
Close Feb 14 16:00 ET
- 1.540
- -0.040-2.53%
Post 20:01 ET
276.58MMarket Cap-19.75P/E (TTM)
1.580High1.480Low1.18MVolume1.550Open1.560Pre Close1.82MTurnover8.91%Turnover RatioLossP/E (Static)175.05MShares8.49052wk High-21.35P/B20.95MFloat Cap0.25652wk Low--Dividend TTM13.26MShs Float21.090Historical High--Div YieldTTM6.41%Amplitude0.256Historical Low1.537Avg Price1Lot Size
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Tevogen Bio Holdings Stock Forum
Tevogen Bio's Financial Strategy: How This Biotech Achieves 600% Higher Market Cap Per Employee
Tevogen Bio's Revolutionary Cost Strategy Reshapes Biotech Economics While Chinese Rivals Surge
Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology's Potential as a Scalable Medical Countermeasure
Friday, 7th February at 2:56 pm
WARREN, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ: TVGN), a clinical-stage specialty immunotherapy biotech company, met the Center for the Biomedical Advanced Research and Development Authority (BARDA) TechWatch team. The discussion focused on Te...
No comment yet